Kristian A Groth1,2, Mette Gaustadnes2, Kasper Thorsen2, John R Østergaard3, Uffe Birk Jensen4, Claus H Gravholt2,5, Niels H Andersen1. 1. Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark. 2. Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark. 3. Centre for Rare Diseases, Department of Paediatrics, Aarhus University Hospital, Aarhus, Denmark. 4. Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark. 5. Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark.
Abstract
PURPOSE: The diagnostic criteria of Marfan syndrome (MFS) highlight the importance of a FBN1 mutation test in diagnosing MFS. As genetic sequencing becomes better, cheaper, and more accessible, the expected increase in the number of genetic tests will become evident, resulting in numerous genetic variants that need to be evaluated for disease-causing effects based on database information. The aim of this study was to evaluate genetic variants in four databases and review the relevant literature. METHODS: We assessed background data on 23 common variants registered in ESP6500 and classified as causing MFS in the Human Gene Mutation Database (HGMD). We evaluated data in four variant databases (HGMD, UMD-FBN1, ClinVar, and UniProt) according to the diagnostic criteria for MFS and compared the results with the classification of each variant in the four databases. RESULTS: None of the 23 variants was clearly associated with MFS, even though all classifications in the databases stated otherwise. CONCLUSION: A genetic diagnosis of MFS cannot reliably be based on current variant databases because they contain incorrectly interpreted conclusions on variants. Variants must be evaluated by time-consuming review of the background material in the databases and by combining these data with expert knowledge on MFS. This is a major problem because we expect even more genetic test results in the near future as a result of the reduced cost and process time for next-generation sequencing.Genet Med 18 1, 98-102.
PURPOSE: The diagnostic criteria of Marfan syndrome (MFS) highlight the importance of a FBN1 mutation test in diagnosing MFS. As genetic sequencing becomes better, cheaper, and more accessible, the expected increase in the number of genetic tests will become evident, resulting in numerous genetic variants that need to be evaluated for disease-causing effects based on database information. The aim of this study was to evaluate genetic variants in four databases and review the relevant literature. METHODS: We assessed background data on 23 common variants registered in ESP6500 and classified as causing MFS in the Human Gene Mutation Database (HGMD). We evaluated data in four variant databases (HGMD, UMD-FBN1, ClinVar, and UniProt) according to the diagnostic criteria for MFS and compared the results with the classification of each variant in the four databases. RESULTS: None of the 23 variants was clearly associated with MFS, even though all classifications in the databases stated otherwise. CONCLUSION: A genetic diagnosis of MFS cannot reliably be based on current variant databases because they contain incorrectly interpreted conclusions on variants. Variants must be evaluated by time-consuming review of the background material in the databases and by combining these data with expert knowledge on MFS. This is a major problem because we expect even more genetic test results in the near future as a result of the reduced cost and process time for next-generation sequencing.Genet Med 18 1, 98-102.
Authors: H C Dietz; G R Cutting; R E Pyeritz; C L Maslen; L Y Sakai; G M Corson; E G Puffenberger; A Hamosh; E J Nanthakumar; S M Curristin Journal: Nature Date: 1991-07-25 Impact factor: 49.962
Authors: S Sheikhzadeh; C Kade; B Keyser; M Stuhrmann; M Arslan-Kirchner; M Rybczynski; A M Bernhardt; C R Habermann; M Hillebrand; T Mir; P N Robinson; J Berger; C Detter; S Blankenberg; J Schmidtke; Y von Kodolitsch Journal: Clin Genet Date: 2011-10-05 Impact factor: 4.438
Authors: Bart L Loeys; Harry C Dietz; Alan C Braverman; Bert L Callewaert; Julie De Backer; Richard B Devereux; Yvonne Hilhorst-Hofstee; Guillaume Jondeau; Laurence Faivre; Dianna M Milewicz; Reed E Pyeritz; Paul D Sponseller; Paul Wordsworth; Anne M De Paepe Journal: J Med Genet Date: 2010-07 Impact factor: 6.318
Authors: Michael O Dorschner; Laura M Amendola; Emily H Turner; Peggy D Robertson; Brian H Shirts; Carlos J Gallego; Robin L Bennett; Kelly L Jones; Mari J Tokita; James T Bennett; Jerry H Kim; Elisabeth A Rosenthal; Daniel S Kim; Holly K Tabor; Michael J Bamshad; Arno G Motulsky; C Ronald Scott; Colin C Pritchard; Tom Walsh; Wylie Burke; Wendy H Raskind; Peter Byers; Fuki M Hisama; Deborah A Nickerson; Gail P Jarvik Journal: Am J Hum Genet Date: 2013-09-19 Impact factor: 11.025
Authors: D O Robinson; F Lin; M Lyon; M Raponi; E Cross; H E White; H Cox; J Clayton-Smith; D Baralle Journal: Clin Genet Date: 2011-09-30 Impact factor: 4.438
Authors: Gwenaëlle Collod-Béroud; Saga Le Bourdelles; Lesley Ades; Leena Ala-Kokko; Patrick Booms; Maureen Boxer; Anne Child; Paolo Comeglio; Anne De Paepe; James C Hyland; Katerine Holman; Ilkka Kaitila; Bart Loeys; Gabor Matyas; Lieve Nuytinck; Leena Peltonen; Terhi Rantamaki; Peter Robinson; Beat Steinmann; Claudine Junien; Christophe Béroud; Catherine Boileau Journal: Hum Mutat Date: 2003-09 Impact factor: 4.878
Authors: Melissa J Landrum; Jennifer M Lee; George R Riley; Wonhee Jang; Wendy S Rubinstein; Deanna M Church; Donna R Maglott Journal: Nucleic Acids Res Date: 2013-11-14 Impact factor: 16.971
Authors: Kristian A Groth; Kirstine Stochholm; Hanne Hove; Kasper Kyhl; Pernille A Gregersen; Niels Vejlstrup; John R Østergaard; Claus H Gravholt; Niels H Andersen Journal: Clin Res Cardiol Date: 2016-08-22 Impact factor: 5.460
Authors: Kristian A Groth; Yskert Von Kodolitsch; Kerstin Kutsche; Mette Gaustadnes; Kasper Thorsen; Niels H Andersen; Claus H Gravholt Journal: Genet Med Date: 2016-12-01 Impact factor: 8.822
Authors: Kristian A Groth; Hanne Hove; Kasper Kyhl; Lars Folkestad; Mette Gaustadnes; Niels Vejlstrup; Kirstine Stochholm; John R Østergaard; Niels H Andersen; Claus H Gravholt Journal: Orphanet J Rare Dis Date: 2015-12-02 Impact factor: 4.123
Authors: Rubén Cabanillas; Marta Diñeiro; David Castillo; Patricia C Pruneda; Cristina Penas; Guadalupe A Cifuentes; Álvaro de Vicente; Noelia S Durán; Rebeca Álvarez; Gonzalo R Ordóñez; Juan Cadiñanos Journal: Mol Genet Genomic Med Date: 2017-04-23 Impact factor: 2.183